Đang chuẩn bị liên kết để tải về tài liệu:
Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The aim of this study was to investigate the potential of cell-free DNA (cfDNA) as a disease biomarker in oesophageal squamous cell carcinoma (ESCC) that can be used for treatment response evaluation and early detection of tumour recurrence. | Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients

TÀI LIỆU LIÊN QUAN

MPD: Multiplex primer design for nextgeneration targeted sequencing

TarSVM: Improving the accuracy of variant calls derived from microfluidic PCR-based targeted next generation sequencing using a support vector machine

Characterization of background noise in capture-based targeted sequencing data

Comparing variant calling algorithms for target-exon sequencing in a large sample

Case report: Whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies

DeviCNV: Detection and visualization of exon-level copy number variants in targeted next-generation sequencing data

High-throughput PCR assay design for targeted resequencing using primerXL

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: Prevalence of actionable mutations among 380 targeted sequencing analyses

Exploring the possibility of predicting human head hair greying from DNA using whole-exome and targeted NGS data

PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data